Quantinno Capital Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
Other funds holding PBE
Quantinno Capital Management's PBE Position: Q3 2026 in Review
Quantinno Capital Management opened a new position in Invesco Biotechnology & Genome ETF (PBE) in Q3 2026: 14,505 shares worth $1.41M. The stake represents ﹤0.01% of the portfolio and ranks #2497 among its holdings.
123 funds tracked by Wall St. Rank hold PBE as of Q3 2026.
- Quantinno Capital Management held 14,505 shares of Invesco Biotechnology & Genome ETF worth $1.41M as of Q3 2026.
- Invesco Biotechnology & Genome ETF was a new Quantinno Capital Management position in Q3 2026.
- Invesco Biotechnology & Genome ETF made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2497 holding.
- 123 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.